vimarsana.com

Page 98 - சிட்டி குழுமம் உலகளாவிய சந்தைகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hudson Executive Investment Corp II Announces Closing of $250 Million Initial Public Offering

Share this article Share this article NEW YORK, Jan. 28, 2021 /PRNewswire/  Hudson Executive Investment Corp. II (the Company ) announced today that it closed its initial public offering of 25,000,000 units at a price of $10.00 per unit, including 2,500,000 units issued pursuant to the exercise by the underwriters of their over-allotment option. The units are listed on The Nasdaq Capital Market ( Nasdaq ) and began trading under the ticker symbol HCIIU on January 26, 2021. Each unit consists of one share of Class A common stock and one-quarter of a redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols HCII and HCIIW, respectively.

Calliditas Therapeutics launches proposed global offering

Calliditas Therapeutics launches proposed global offering Search jobs Calliditas Therapeutics launches proposed global offering January 26, 2021 Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX – CALTX; Nasdaq – CALT) will today launch a proposed public offering of American Depositary Shares ( ADSs ), in the United States for trading on The Nasdaq Global Select Market in the United States (the “U.S. Offering”) and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States (the Private Placement”, and together with the U.S. Offering, the “Global Offering”). The target size of the Global Offering is 4,500,000 common shares plus a potential 30-day over-allotment option of 15 percent of the common shares (including common shares in the form of ADSs) offered by Calliditas at the U.S. Offering price. The Global Offering is subject to market conditions and investor demand and

HumanCo Acquisition Corp Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing January 28, 2021

Share this article Share this article AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ HumanCo Acquisition Corp. (NASDAQ: HMCOU) (the Company ) announced that, commencing January 28, 2021, holders of the units sold in the Company s initial public offering of 28,750,000 units may elect to separately trade the shares of Class A common stock and redeemable warrants included in the units. Those units not separated will continue to trade on The Nasdaq Capital Market ( Nasdaq ) under the symbol HMCOU, and the shares of Class A common stock and redeemable warrants that are separated will trade on Nasdaq under the symbols HMCO and HMCOW, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company s transfer agent, in order to separate the units into shares of Class A common stock and redeemable warrants.

YPF Sociedad Anónima Announces Second Amendment to Exchange Offers and Consent Solicitation

YPF Sociedad Anónima Announces Second Amendment to Exchange Offers and Consent Solicitation News provided by Share this article YPF or the Company ) today announced its decision to amend the terms and conditions of its Exchange Offers and Consent Solicitation initially described in its Exchange Offer and Consent Solicitation Memorandum dated January 7, 2021, as first amended on January 14, 2021 (the Exchange Offer and Consent Solicitation Memorandum ). Capitalized terms used herein and not otherwise defined shall have the meaning ascribed to them in the Exchange Offer and Consent Solicitation Memorandum. The Company has revised the terms and conditions of the Exchange Offers and Consent Solicitation mainly to:

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.